Thomas Senderovitz, SVP of data science at Novo Nordisk, says automation is infiltrating every part of Novo’s clinical trial system, with reports written by AI and not employees. Senderovitz cited the difficulty of working in a regulated industry, but also said the crafting of AI-generated scientific manuscripts is advancing, leading to a future with fewer humans involved in the process.
Why Healthcare Organisations Have To Act Decisively In The Shadow Of New HIPAA Updates
The recent amendments to the Health Insurance Portability and Accountability Act (HIPAA) represent a significant overhaul in healthcare data privacy, addressing the need to protect
